首页 | 本学科首页   官方微博 | 高级检索  
     

289株VVC致病菌的菌种分布和对9种抗真菌药物敏感性
引用本文:雷岩,陈晓菲,晏亮,张虹,赵蓉芬,华道生,于农,潘炜华,廖万清,邓淑文. 289株VVC致病菌的菌种分布和对9种抗真菌药物敏感性[J]. 菌物学报, 2019, 38(8): 1306-1313. DOI: 10.13346/j.mycosystema.190106
作者姓名:雷岩  陈晓菲  晏亮  张虹  赵蓉芬  华道生  于农  潘炜华  廖万清  邓淑文
作者单位:第二军医大学附属长征医院皮肤科 上海200003;苏州高新区人民医院检验科 江苏苏州215129;中国人民解放军中部战区总医院皮肤科 湖北武汉430070
基金项目:苏州市科委临床重点诊疗技术专项(LCZX201728);苏州高新区卫计局重点项目(2017Z008);苏州高新区医疗卫生青年科技项目(2018Q003);苏州高新区人民医院科学创新面上项目(SGY2019B01);国家自然科学基金(81720108026);上海市医学真菌分子生物学重点实验室项目(17DZ2272900);上海市科委项目(16DZ0500401)
摘    要:外阴阴道念珠菌病(vulvovaginal candidiasis,VVC)是女性的常见病。本研究收集了2018年1月-12月苏州地区VVC患者分离的289株念珠菌进行了病原学鉴定和包括棘白菌素类、新三唑类药物在内的9种抗真菌药物体外敏感性分析。本文采用核糖体RNA的D1/D2基因进行念珠菌菌种鉴定。参照M27-A3方法检测其对9种抗真菌药物(包括棘白菌素类及新三唑类药物)的体外敏感性。结果表明,289株VVC念珠菌菌株中,白念珠菌259株、光滑念珠菌14株、克柔念珠菌10株、热带念珠菌4株、近平滑念珠菌2株。259株VVC白念珠菌对棘白菌素类体外敏感性好,对米卡芬净敏感性高于另外两种棘白菌素类;对两性霉素B、5-氟胞嘧啶、氟康唑敏感性好;但对伊曲康唑、伏立康唑敏感性差;对泊沙康唑敏感性好。光滑念珠菌株和克柔念珠菌分离株对卡泊芬净敏感性差,但对米卡芬净、阿尼芬净敏感性好;光滑念珠菌株对两性霉素B、5-氟胞嘧啶体外敏感性好,对伊曲康唑敏感性差,对泊沙康唑敏感性好;伏立康唑对光滑念珠菌分离株MIC50/90为0.5/1μg/mL;克柔念珠菌对伊曲康唑、伏立康唑50%耐药;4株热带念珠菌对伊曲康唑50%耐药,对卡泊芬净、氟康唑、伏立康唑100%耐药,对其余5种抗真菌药物敏感。近平滑念珠菌对9种抗真菌药物均敏感。白念珠菌仍为苏州地区VVC的主要病原菌,其次是光滑念珠菌和克柔念珠菌,它们对临床常用药物伊曲康唑、伏立康唑、卡泊芬净敏感性差。研究结果提示对VVC病人常规进行分泌物培养、菌种鉴定,对苏州地区临床医生制定VVC治疗方案具有重要参考价值。尽管棘白菌素类、两性霉素B、5-氟胞嘧啶、新三唑类药物尚未应用到VVC的临床治疗中,但是这些药物对VVC病原体总体敏感性较好,未来有望成为氟康唑、咪唑类药物治疗失败患者的新选择。

关 键 词:外阴阴道念珠菌病  抗真菌敏感性  抗真菌药  鉴定
收稿时间:2019-04-03

Identification of 289 isolates of VVC pathogens and sensitivity of the pathogens to 9 antifungal drugs
Yan LEI,Xiao-Fei CHEN,Liang YAN,Hong ZHANG,Rong-Fen ZHAO,Dao-Sheng HUA,Nong YU,Wei-Hua Pan,Wan-Qing LIAO,Shu-Wen DENG. Identification of 289 isolates of VVC pathogens and sensitivity of the pathogens to 9 antifungal drugs[J]. Mycosystema, 2019, 38(8): 1306-1313. DOI: 10.13346/j.mycosystema.190106
Authors:Yan LEI  Xiao-Fei CHEN  Liang YAN  Hong ZHANG  Rong-Fen ZHAO  Dao-Sheng HUA  Nong YU  Wei-Hua Pan  Wan-Qing LIAO  Shu-Wen DENG
Affiliation:1. Clinical Laboratory, Suzhou High-tech Zone People’s Hospital, Suzhou, Jiangsu 215129, China2. Department of Dermatology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China3. Department of Dermatology, Central Military Theater, Chinese People’s Liberation Army, Wuhan, Hubei 430070, China
Abstract:Vulvovaginal candidiasis (VVC) is a common disease in women. In this study, 289 isolates of Candida spp. were obtained from VVC patients in Suzhou from January to December 2018. Identification and the test of in vitro susceptibility to nine antifungal drugs including echinocandins and neotriazoles of the pathogens were couducted. The D1/D2 gene of ribosomal RNA was used to identify Candida species. The in vitro sensitivity was tested by using M27-A3 protocol. Among 289 isolates, there were 259 isolates of Candida albicans, 14 isolates of Candida glabrata, 10 isolates of Candida krusei, 4 isolates of Candida tropicalis, and 2 isolates of Candida parapsilosis. Candida albicans showed high sensitivity to echinocanins in vitro, and its sensitivity to micafungin was higher than that to the other two echinocandins tested. It is sensitive to amphotericin B, 5-fluorocytosine and fluconazole, but less sensitive to itraconazole and voriconazole; it is also sensitive to posaconazole. Candida glabrata and Candida krusei have poor sensitivity to caspofungin, but have high sensitivity to micafungin and anidulafungin. The sensitivity of Candida glabrata to amphotericin B, 5-fluorocytosine and posaconazole is high, but poor to itraconazole. The MIC50/90 of Candida glabrata isolate to voriconazole is 0.5/1μg/mL in vitro. Candida krusei reveals 50% resistance to itraconazole and voriconazole; 4 isolates of Candida tropicalis display 50% resistance to itraconazole and 100% resistance to caspofungin, fluconazole, and voriconazole, and are sensitive to other 5 antifungal drugs. Candida parapsilosis was sensitive to 9 antifungal drugs. Candida albicans is predominant pathogen causing VVC in Suzhou, while Candida glabrata and Candida krusei. Secondary, showing lower sensitivity to itraconazole, voriconazole and caspofungin. The results indicate that periodical routine secretion examination culture and identification of pathogens are of benefit to local clinicians in Suzhou to develop a proper VVC treatment plan. Although echinomycin, amphotericin B, 5-fluorocytosine, and neotriazole have not been applied to the clinical treatment of VVC, these drugs are generally more sensitive to VVC pathogens and are expected to become a new choice for VVC patients.
Keywords:vulvovaginal candidiasis  antifungal sensitivity  antifungal drugs  identification  
本文献已被 万方数据 等数据库收录!
点击此处可从《菌物学报》浏览原始摘要信息
点击此处可从《菌物学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号